✦ LIBER ✦

Omalizumab is well tolerated in adolescent/adult patients (≥12 Years) with moderate-to-severe persistent asthma

✍ Scribed by Corren, J.; Casale, T.; Lanier, B.Q.; Blogg, M.; Reisner, C.; Gupta, N.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once-daily ciclesonide is effective and

✍ Pearlman, D.; Creticos, P.; Lampl, K.; Gower, R.; Kundu, S.; Fish, J.; Williams, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 31 KB

Cost-effectiveness analysis of omalizuma

✍ Oba, Yuji; Salzman, Gary A 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Effectiveness of omalizumab in reducing

✍ Karpel, Jill; Massanari, Marc; Geba, Gregory P.; Kianifard, Farid; Inhaber, Neil 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 248 KB

Once-daily ciclesonide improves lung fun

✍ PEARLMAN, D; BERGER, W; KERWIN, E; LAFORCE, C; KUNDU, S; BANERJI, D 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Reasons for Discontinuation of Omalizuma

✍ SHEINKOPF, L; RAFI, A; DO, L; KLAUSTERMEYER, W; KATZ, R 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Efficacy and tolerability of anti-immuno

✍ J. G. Ayres; B. Higgins; E. R. Chilvers; G. Ayre; M. Blogg; H. Fox 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB